Holen Sie sich die Stockscreener-App
85.33
1.90%
1.595
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Medtronic Plc Aktie (MDT) Neueste Nachrichten
DBS Bank Adjusts Price Target on Medtronic to $82 From $90, Maintains Hold Rating - marketscreener.com
Is Medtronic Stock Underperforming The Dow? - Barchart.com
How Much Would It Take To Earn $100 A Month From Medtronic Stock - Benzinga
Medtronic (MDT) Sees Increased Bullish Options Activity | MDT Stock News - GuruFocus
Medtronic to spin off its diabetes businessreport - MSN
Medtronic is telling workers to return to the office more - MassDevice
The Strong Earnings Posted By Medtronic (NYSE:MDT) Are A Good Indication Of The Strength Of The Business - Yahoo Finance
Medtronic (NYSE:MDT) Will Pay A Larger Dividend Than Last Year At $0.71 - simplywall.st
Medtronic Strengthens Return-to-Office Requirements for Hybrid Employees - Medical Device and Diagnostic industry
Medtronic plc (MDT): A Bull Case Theory - MSN
Medtronic at Bernstein Conference: Strategic Focus on Growth and Innovation By Investing.com - Investing.com UK
Transcript : Medtronic plc Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-29-2025 11 - marketscreener.com
Medtronic Splits, Boston Scientific Exits TAVR, J&J Loses Big - Medical Device and Diagnostic industry
Medtronic To Present At Bernstein's Strategic Decisions Conference; Webcast At 11:00 AM ET - Nasdaq
Drug Device Combination Products Market Analysis Report 2025-2030: Discover the Latest Advances and Opportunities - GlobeNewswire Inc.
Medtronic : receives FDA’s Safer Technologies Program (STeP) designation for its investigational Nellcor™ pulse oximetry technology - marketscreener.com
Medtronic (MDT) Price Target Reduced but Long-Term Buy Rating Maintained | MDT Stock News - GuruFocus
Argus Adjusts Price Target on Medtronic to $105 From $120 - marketscreener.com
Medtronic’s SWOT analysis: medical device giant faces tariffs, sees growth in RDN - Investing.com
Atherectomy Devices Market Growth in Future Scope 2025-2032 | - openPR.com
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade (NYSE:MDT) - Seeking Alpha
Medtronic to separate diabetes business following recent struggles - MSN
Medtronic plc (NYSE:MDT) Q4 2025 Earnings Call Transcript - MSN
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's - Yahoo Finance
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference | MDT Stock News - GuruFocus
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference - Yahoo
Sector Update: Health Care - marketscreener.com
Medtronic to Split Off Diabetes Unit as Tariffs Hit Earnings - MSN
September 2026 Options Now Available For Medtronic (MDT) - Nasdaq
Redburn Atlantic Adjusts Price Target on Medtronic to $101 From $104 - marketscreener.com
JPMorgan Adjusts Medtronic Price Target to $87 From $95 - marketscreener.com
Jim Cramer on Medtronic (MDT): “I Like This Medical Device Powerhouse” - Insider Monkey
Blood Glucose Monitoring (BGM) Devices Market Report 2025: Hospitals Lead in Blood Glucose Monitoring Device Usage, Home Care Grows Fastest - GlobeNewswire Inc.
Endoscopy Devices Global Market Overview 2021-2030 with Forecasts 2024-2030 - GlobeNewswire Inc.
Medtronic Projects $350M Tariff Hit - Medical Device and Diagnostic industry
Medtronic to separate diabetes business into standalone company - MSN
Medtronic Announces Separation From Diabetes Business, CEO Says it’s “In a Really Good Spot” - Insider Monkey
Medtronic has new Cardiovascular, CST leaders after longtime exec departs - MassDevice
Medtronic (MDT) Plans to Spin Off Diabetes Business - GuruFocus
TD Cowen Keeps a Buy on Medtronic (MDT) After Better Growth in Q4 - Insider Monkey
Medtronic PLC stock underperforms Thursday when compared to competitors - MarketWatch
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better? - Yahoo Finance
Medtronic PLC (MDT) Stock Price Down 3.66% on May 22 - GuruFocus
Medtronic to separate diabetes business, WSJ reports - MSN
MDT: RBC Capital Lowers Price Target for Medtronic | MDT Stock N - GuruFocus
Medtronic (MDT) Stock Price Target Lowered by Mizuho Analyst | M - GuruFocus
Medtronic inks expanded distro deal for multi-parameter wearable vital sign monitor - MassDevice
Medtronic's Strong Q4 Performance Sets The Stage For Future Growth - Finimize
Medtronic (MDT) Price Target Lowered by Baird Analyst | MDT Stoc - GuruFocus
Medtronic (MDT) Price Target Lowered by Baird Analyst | MDT Stock News - GuruFocus
Medtronic Cardiovascular Strength Drives Fiscal Q4 Beat, RBC Says - marketscreener.com
Why Medtronic plans to spin out its diabetes business - MedTech Dive
July 3rd Options Now Available For Medtronic (MDT) - Nasdaq
Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon - MassDevice
Medtronic (MDT) Price Target Lowered by RBC Capital Amid Growth Investments | MDT Stock News - GuruFocus
0.19%
1.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):